Myeloma Trial, Recruiting NCT05312255 Sponsor: Roswell Park Cancer Institute Condition: Myeloma
Back to Myeloma

Myeloma Trial, Recruiting

NCT05312255
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years of age or older.
  • You must be well enough to carry out daily activities to a certain level — the exact level required depends on which part (module) of the trial you are joining (confirm with trial site).
  • For Modules A, B, and C: You have been diagnosed with smoldering multiple myeloma, multiple myeloma, or plasma cell leukemia.
  • For Module D: You have been diagnosed with a low-risk blood condition called MDS (myelodysplastic syndrome) and do not currently need blood transfusions.
  • Your doctor has assessed that it is safe for you to take part in the study based on your overall health.
  • You are able to understand and follow the study procedures and instructions.
  • You must be willing to sign a written consent form before joining the study.
  • For Modules A and D (Physical Activity): You have access to a personal computer or tablet with a camera, microphone, speakers, and internet connection.
  • For Module C (Beta Blocker): You have newly diagnosed multiple myeloma that requires treatment, but you have not yet started that treatment.
  • For Module C: If you are a woman who could become pregnant, you must have a negative pregnancy test before starting and agree to use reliable contraception during the study; men with partners who could become pregnant should also use contraception.
  • For Module D: You have not needed a blood transfusion in the 8 weeks before enrolling and are either being monitored, or taking growth factor treatments or a drug called luspatercept only.

Who may not be able to join:

  • You have serious health conditions that could put you at risk during the study, such as active infection, heart failure, unstable chest pain, irregular heartbeat, or serious lung disease.
  • You have a mental health condition or personal circumstances that would make it difficult to follow the study requirements.
  • You are unwilling or unable to follow the study plan.
  • Your doctor feels that, for any reason, you are not a suitable candidate for the study.
  • For Module A (Physical Activity): You currently have a painful broken bone caused by your disease, or serious instability of your bones or muscles that makes exercise unsafe.
  • For Module A (Physical Activity): A bone scan has shown that your bones are too unstable to safely take part in physical activity (as assessed by an experienced surgeon).
  • For Module B (Nutrition): Your body weight is too low, indicating signs of malnutrition (BMI below 18).
  • For Module B (Nutrition): You are following a special diet prescribed by a doctor.
  • For Module B (Nutrition): You have diabetes and are taking medication or insulin to control your blood sugar.
  • For Module B (Nutrition): You have any other condition that means you should not restrict your food intake (confirm with trial site).
  • For Module C (Beta Blocker): You are currently taking, or have taken in the last 3 months, a type of heart medication called a beta-blocker.
  • For Module C (Beta Blocker): You have certain heart, lung, blood pressure, or other conditions that mean beta-blocker medication would not be safe for you — including very slow heart rate, heart block, uncontrolled heart failure, low blood pressure, severe asthma, uncontrolled diabetes, certain circulation problems, or if you have a pacemaker (confirm with trial site for full list).
  • For Module C (Beta Blocker): You are currently pregnant or breastfeeding.
  • For Module D: A heart specialist (cardiologist) has determined that your heart condition makes it unsafe for you to exercise.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Roswell Park Cancer Institute
Registry
ClinicalTrials.gov
Start date
28 June 2022
Est. completion
28 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Changes in immune cell subsets

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov